• Ângela Cristine Bersch-Ferreira, Geni Rodrigues Sampaio, Marcella Omena Gehringer, Maria Beatriz Ross-Fernandes, Cristiane Kovacs, Renata Alves, Jaqueline Lopes Pereira, Carlos Daniel Magnoni, Bernardete Weber, and Marcelo Macedo Rogero.
• Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil; Research Institute, Hospital do Coracção (IP-HCor), São Paulo, SP, Brazil.
• Nutrition. 2017 May 1; 37: 30-36.

ObjectiveThe aim of this study was to assess the association between polyunsaturated fatty acids (PUFAs) and inflammatory biomarkers among patients in secondary prevention of cardiovascular disease (CVD).MethodsIn this cross-sectional substudy from BALANCE Program Trial, we have collected data from 364 patients with established CVD. Twenty-four-hour dietary recalls and plasma FA concentrations were analyzed to estimate the FA intake. Inflammatory biomarkers measurement consisted of interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12, C-reactive protein, adiponectin, and tumor necrosis factor-α. After log-transformation of inflammatory biomarkers, multivariate-adjusted general linear model was used to examine the effect of FA intake. The association was adjusted for body mass index, waist circumference, energy, smoking status, age, total cholesterol, low-density lipoprotein cholesterol, physical activity, and calcium channel blockers.ResultsPUFAs were inversely associated with C-reactive protein levels (P = 0.006) and with IL-1 β. The increase of 1 g/1000 kcal in PUFAs, omega-3, and omega-6 reduces, on average, 6%, 48%, and 8% respectively, the mean concentration of IL-1 β.ConclusionOmega-3 and omega-6 FA intakes are inversely associated with inflammatory biomarkers among CVD patients. Additional studies on omega-3 and omega-6 intake in relation to inflammatory biomarkers in patients in secondary prevention of CVD are needed, particularly regarding dietary patterns that are rich in some sources of PUFA.Copyright © 2016 Elsevier Inc. All rights reserved.

35 keywords...

hide…